HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- The cancer-fighting pill Iressa works as well as chemotherapy as a second-line treatment for lung cancer, researchers report.

AP - Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo by taking a pill instead, a study suggests. An international study showed patients on Iressa, an expensive, newer targeted treatment, survived about as long as those on another course of chemotherapy.

Reuters - The lung cancer pill Iressa has shown surprising results for patients with advanced disease where it has been at least as effective as a standard chemotherapy treatment, researchers reported on Thursday.

Reuters - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report.

HealthDay - MONDAY, Nov. 17 (HealthDay News) -- Doctors may someday be able to use five genetic markers to assess whether a man is at high risk to develop prostate cancer, a new study suggests.

Reuters - Middle-aged men who take aspirin or other "nonsteroidal anti-inflammatory drug" (NSAID) have significantly lower levels of a blood protein used to spot prostate cancer than men who don't take these widely used drugs, a study shows.

HealthDay - SUNDAY, Nov. 16 (HealthDay News) -- Coming on the heels of two studies discounting the usefulness of vitamin B, folic acid, vitamin D and calcium supplements for cancer prevention, U.S. researchers report that vitamins C and E supplements won't help prevent cancer, either.

Reuters - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate.

Reuters - A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features.

HealthDay - THURSDAY, Oct. 30 (HealthDay News) -- A new study shows that men who take cholesterol-lowering drugs called statins have lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk.

American Cancer Society - The National Cancer Institute has stopped a major clinical trial studying whether vitamin E and selenium can prevent prostate cancer because early analysis suggests the supplements don't work. What's more, there is some evidence that they may actually be harmful.

Reuters - Cholesterol-lowering drugs called statins modestly reduce levels of a protein in a man's blood that doctors often use to screen for prostate cancer, researchers said on Tuesday.

Reuters - Selenium and vitamin E supplements do not prevent prostate cancer and may in fact be a little bit dangerous, U.S. researchers reported on Monday.

AP - The government is stopping a major study of whether vitamin E and selenium prevent prostate cancer — because the supplements aren't working and there's a hint of risk.

Reuters - Exposure to bisphenol A (BPA) -- a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans -- may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.

Reuters - A mutated gene previously linked to breast cancer has been found in 70 percent of prostate tumors as well, U.S. researchers reported on Friday.

HealthDay - WEDNESDAY, Oct. 22 (HealthDay News) -- Using just a single adult stem cell, scientists say they have grown entire prostates in mice.

AFP - Molecular biologists reported Wednesday that they had grown prostates in mice from single cells, marking an important step forward in the quest to grow transplant tissue in the lab.

HealthDay - WEDNESDAY, Oct. 22 (HealthDay News) -- Using just a single adult stem cell, scientists say they have grown entire prostates in mice.

HealthDay - FRIDAY, Oct. 17 (HealthDay News) -- With increasing life expectancies, improved surgical tools, and better information on patient results, many older men diagnosed with early prostate cancer are taking a pass on the traditional advice to hold off on treatment for a period of time.